hsa-miR-31

ncRNA information

ncRNA name

hsa-miR-31

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

Src

Cancer information

Cancer name

Gallbladder Cancer

Cancer site

Gallbladder

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Up

Impact of overexpression of ncRNA on chemotherapy resistance

Down

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Down

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Our results demonstrated that miR-31reduced significantly in GBC cells rendering resistance to cisplatin, and upregulated expression of miR-31 augmented chemosensitivity, presenting a therapeutic potential to overcome drug.

Tissue resource

gallbladder cancer tissues and casematched noncancerous tissues

human gallbladder cancer cell lines NOZ

human gallbladder cancer cell lines GBC-SD

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

Xinhua Hospital, School of Medicine, Shanghai JiaoTong University

the Cell Bank of Type Culture Collection of the Chinese Academy of Sciences

Country

China

Continent

Asia